Vertel uw vrienden over dit artikel:
Target Validation in Drug Discovery
Dillon
Target Validation in Drug Discovery
Dillon
Presents a comprehensive framework for approaching target validation in drug discovery. This work begins with a description of enabling technologies, including aptamers, RNA interference, and proteomics. It, then, looks at biologic drug development with discussion of lessons learned from such well-known cases as Erbitux, Herceptin, and Avastin.
296 pages, Illustrated
Media | Boeken Hardcover Book (Boek met harde rug en kaft) |
Vrijgegeven | 1 september 2006 |
ISBN13 | 9780123693938 |
Uitgevers | Elsevier Science Publishing Co Inc |
Pagina's | 296 |
Afmetingen | 184 × 260 × 24 mm · 820 g |
Uitgever | Dillon, Susan (Senior Vice President, Discovery Research Centocor, Johnson & Johnson, Malvern, PA, U.S.A.) |
Uitgever | Metcalf, Brian W. (Chief Drug Discovery Officer, Incyte Corporation, Moraga, CA, U.S.A.) |
Alles tonen
Meer door Dillon
Anderen hebben ook gekocht
Bekijk alles van Dillon ( bijv. Book , CD , LP , Hardcover Book en Paperback Book )